The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers.
about
Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta geneGestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brainProstate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines.Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate CancerEpigenetic changes in prostate cancer: implication for diagnosis and treatment.Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.Epigenetics of prostate cancer: beyond DNA methylationRetinoic acid receptors and GATA transcription factors activate the transcription of the human lecithin:retinol acyltransferase gene.The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.Aberrant DNA methylation and prostate cancer.Retinoids in cancer therapy and chemoprevention: promise meets resistance.Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance.Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.Downregulation of retinoic acid receptor-beta(2) expression is linked to aberrant methylation in esophageal squamous cell carcinoma cell lines.Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours.Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylationEpigenetic targets in the diagnosis and treatment of prostate cancer.Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancerBiomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate modelProstate cancer epigenetics: a review on gene regulation.Promoter hypermethylation in prostate cancer.The epigenome as a therapeutic target in prostate cancer.The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis.Circulating nucleic acids as biomarkers of prostate cancer.Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model.DNA methylation in promoter region as biomarkers in prostate cancer.Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer.RARβ2-dependent signaling represses neuronal differentiation in mouse ES cells.Identification of differentially methylated CpG islands in prostate cancer.Epigenetic Mechanisms in Cancer Formation and Progression
P2860
Q28235706-EA69BCFD-C87A-4296-AF45-2545C2C333CDQ28564910-0AD6FC46-A01D-4B59-A5CD-28AE40383139Q30769366-CFF7F8B7-6F2D-4D75-83B0-C3D980D7CE35Q33202648-D0F1288D-75D7-45F4-A684-E1F16F22658EQ34014559-5C4FDC51-FEA8-4D1D-B989-31DD5BBBADCCQ34160419-AD35BA80-3392-4BE5-A047-F808F1B76540Q34324983-D1E742C3-E22C-4346-8726-F1514E6FDC1BQ34385658-D396E313-1555-4F16-B4D1-D034C454D462Q34423868-7592877E-8767-4383-BEC1-11ACD6CF7D92Q34505232-7B5F541E-B9B4-4D69-B3DE-161494FA35F9Q34656797-F5B94A56-0C87-41E9-9258-2393F901F45AQ35191267-4D906C17-6962-42F5-848A-F3B2C0DDA3F2Q35560819-8C0E0A36-1690-4BB0-A2EA-D48F2F03086FQ35567239-0F05363D-7512-4E41-B1F9-F5AD32554CFEQ36008112-1C4D617D-2887-4A84-A725-E31B94F73E9DQ36076356-766186EA-76C5-4C1D-824C-40E99422547DQ36502536-90205A50-787A-4D87-B625-C16112D62D5EQ36571511-F1CBD4B0-549A-4C42-8C6B-047D6A31C318Q36608545-80E180A5-E2EE-4B55-86E5-54603CA596B0Q36695645-85F0C742-B50C-4E90-BA14-D7FA1F8EE131Q36750234-0E1F9DA4-EFE4-4041-8302-03FE85B2414EQ36888332-3D76F78F-63B5-4F83-99A3-32DD3A869A26Q36920773-F9C02E10-5D7F-4709-B9B7-174F25621174Q36932335-D05091C2-81D5-4E75-A383-BCCF9D4CBAD1Q37365555-2C03B8A1-1F7F-4810-A903-588FFE16EA6BQ37380585-9285C413-2686-4800-BBE1-C0AB11E52E72Q37791396-0CA3C414-E020-4E42-92FC-A6ECC75A75A4Q37808106-586D3F3D-3C61-405F-A431-E2DAECD22326Q38106981-48510C11-F913-4F68-ABB7-F60E493661C8Q38165244-777C753E-0C47-474B-8E9F-DA87EE737E58Q38874309-EF71AE25-ABBB-4423-8E4A-32CA2C947564Q39992913-6A0783E1-3327-47E4-8744-33BB7E54BA3AQ40408651-F4D0678D-C997-42C7-9018-684AF496415AQ40470869-0AF49FB1-E0DB-429F-A626-AFC771E7FC17Q40601236-9ECE8E7E-F80E-48DE-BE14-43224AFCAA5DQ42261678-7E617771-08FD-433C-BE24-699DAB2331E5Q44490305-BA90D9FD-B281-428A-86C5-F0B8DFEE9FE9Q47386833-106F40D7-C167-41EE-9259-AC053DF2C4D0Q53364687-3FF8C871-5219-4A66-A940-E0574453C0D6Q57570317-8EF3DCCA-E732-4A2C-9E77-A447407A22D5
P2860
The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The role of epigenetic modific ...... ion in human prostate cancers.
@en
The role of epigenetic modific ...... ion in human prostate cancers.
@nl
type
label
The role of epigenetic modific ...... ion in human prostate cancers.
@en
The role of epigenetic modific ...... ion in human prostate cancers.
@nl
prefLabel
The role of epigenetic modific ...... ion in human prostate cancers.
@en
The role of epigenetic modific ...... ion in human prostate cancers.
@nl
P2093
P2860
P1476
The role of epigenetic modific ...... ion in human prostate cancers.
@en
P2093
Hirokawa Y
Nakayama T
Shiraishi T
Watanabe M
Yamanaka M
P2860
P2888
P304
P356
10.1038/LABINVEST.3780316
P577
2001-07-01T00:00:00Z